Bowel cancer screening across England is detecting approximately 100 cancers every week, according to annual figures published by NHS England covering the period from April 2024 to March 2025. Despite that detection rate, the data points to a persistent gap in uptake among those in their 50s — the youngest cohort invited to participate.
What the Figures Show
Of all the age groups eligible for bowel cancer screening, people in their early-to-mid 50s were among the least likely to return their home testing kits during the 2024–25 reporting year. NHS England's data recorded that just 56.2% of 54-year-olds completed the screening process — meaning roughly four in ten people in that age bracket did not return a kit at all.
The figures form part of the health service's broader push to raise awareness of the programme, which posts a stool sample test to eligible individuals. The test, known as a faecal immunochemical test (FIT), checks for traces of blood that may not be visible to the naked eye and can indicate the presence of polyps or early-stage cancer.
Why Uptake in the 50s Matters
Bowel cancer is among the most common cancers diagnosed in England, and clinical evidence has long supported the value of catching it at an earlier stage, when treatment is generally more straightforward. The expansion of the NHS screening programme to include people from age 50 — previously the threshold was 60 — was intended to widen that early-detection window.
The lower participation rate observed among those newly eligible raises questions about awareness and engagement. NHS England's release of these figures appears intended, in part, to draw attention to that gap. The fact that the programme is finding around 100 cancers per week through screening alone underscores the volume of cases that might otherwise go undetected until symptoms emerge.
How the Screening Programme Works
Eligible individuals in England are sent a FIT kit by post. The test requires a small sample to be collected at home and returned by post for laboratory analysis. Those whose results indicate a possible abnormality are typically referred for a colonoscopy, which allows clinicians to examine the bowel directly and, where necessary, remove polyps before they develop further.
The process is designed to be completed without a GP visit or clinic appointment, which makes non-return of the kit the primary barrier to participation. Research into screening programmes more broadly has identified factors including low perceived personal risk, inconvenience, and anxiety about results as common reasons people do not complete home-based tests.
Context Within Broader Cancer Screening Trends
Participation rates in cancer screening programmes across the UK have been subject to scrutiny in recent years, particularly following disruptions during the pandemic period that led to a backlog in testing and referrals. NHS England has since reported efforts to recover those numbers, and the bowel screening programme's weekly detection figures suggest the infrastructure is functioning at scale.
Nevertheless, the 56.2% uptake figure for 54-year-olds indicates that a substantial proportion of the population is not engaging with a programme that is free, postal, and requires no clinical contact. Whether targeted communications or changes to how kits are distributed could shift that figure remains an open question for public health researchers and commissioners.
NHS England's annual bowel screening data is published as part of routine reporting on national cancer screening programmes. The figures for 2024–25 represent the most recent full-year snapshot available.